Product Name | MF | CAS | Details |
---|
VEGFR2-IN-2, 10 mM in DMSO | C15H11BrN2O | 737818-56-3 | Details |
Tegaserod | C16H23N5O | 145158-71-0 | Details |
(E)-[6]-Dehydroparadol, 10 mM in DMSO | C17H24O3 | 878006-06-5 | Details |
TLC2976-0103 | C17H15N3O2S | 692869-38-8 | Details |
(±)-Enitociclib, 10 mM in DMSO | C19H18F2N4O2S | 1610358-53-6 | Details |
XX-650-23, 10 mM in DMSO | C18H12N2O2 | 117739-40-9 | Details |
Lecanoric acid, 10 mM in DMSO | C16H14O7 | 480-56-8 | Details |
WAY-639228 | C22H24N2O2S | 179051-05-9 | Details |
Zharp2-1 | C19H18N3O2PS | 2772600-18-5 | Details |
(1R,2S)-VU0155041, 10 mM in DMSO | C14H15Cl2NO3 | 1263273-14-8 | Details |
(+)-JQ1 PA | C22H20ClN5OS | 2115701-93-2 | Details |
VIP(6-28)(human, rat, porcine, bovine) acetate | C126H207N37O34S | Details |
α,α-Dimethylglycine | C4H9NO2 | 62-57-7 | Details |
(+)-PD 128907 hydrochloride, 10 mM in DMSO | C14H19NO3HCl | 300576-59-4 | Details |
2'',4''-Dihydroxy-6''-methoxyacetophenone, 10 mM in DMSO | C9H10O4 | 3602-54-8 | Details |
TG 100801 | C33H30ClN5O3 | 867331-82-6 | Details |
Z-Arg(Z)2-OH, 10 mM in DMSO | C30H32N4O8 | 14611-34-8 | Details |
Topoisomerase II inhibitor 13 | C22H23N9 | 451515-89-2 | Details |
VB 201 | C29H60NO8P | 630112-41-3 | Details |
Syringetin | C17H14O8 | 4423-37-4 | Details |
XY028-133, 10 mM in DMSO | C53H67N11O7S | 2229974-73-4 | Details |
(D-Ser2)-Leu-Enkephalin-Thr | C33H46N6O10 | Details |
(3aR,9aR)-Fluparoxan | C10H10FNO2 | 105182-47-6 | Details |
(1S,2R)-2-PCCA | Details |
THK5351, 10 mM in DMSO | C18H18FN3O2 | 1707147-26-9 | Details |
(1(10)E,2R*,4R*)-2-Methoxy-8,12-epoxygermacra-1(10),7,11-trien-6-one, 10 mM in DMSO | C16H22O3 | 75412-95-2 | Details |
(Arg)9 TFA (143413-47-2 free base) | C56H111F3N36O12 | 2283335-13-5 | Details |
Z-Glycine, 10 mM in DMSO | C10H11NO4 | 1138-80-3 | Details |
YAP-TEAD-IN-1 acetate | Details |
USP28-IN-3 | C23H20Cl2N2O3S | 2931509-14-5 | Details |
UCCF-853 | C14H8ClF3N2O | 625458-06-2 | Details |
4-(Ethoxymethyl)phenol, 10 mM in DMSO | C9H12O2 | 57726-26-8 | Details |
Usenamine A | C18H17NO6 | 1428417-60-0 | Details |
Turosteride | C27H45N3O3 | 137099-09-3 | Details |
VEGFR-2-IN-29 | C16H11N3O3 | 62802-77-1 | Details |
D-Xylose | C5H10O5 | 6763-34-4 | Details |
ZMC1, 10 mM in DMSO | C11H14N4S | 71555-25-4 | Details |
(6R)-FR054, 10 mM in DMSO | C14H19NO8 | 10378-06-0 | Details |
4-Hydroxyindole, 10 mM in DMSO | C8H7NO | 2380-94-1 | Details |
XPW1 | C36H39ClFN7O2 | 2700286-66-2 | Details |
Tyrosinase-IN-16 | C8H6BrN3S | 126651-85-2 | Details |
trans-ACPD, 10 mM in DMSO | C7H11NO4 | 67684-64-4 | Details |
Urease Inhibitor 07, 10 mM in DMSO | C7H5N3OS | 15264-63-8 | Details |
(-)-Coclaurine hydrochloride, 10 mM in DMSO | C17H20ClNO3 | 3422-42-2 | Details |
Triumbelletin | C27H14O9 | 131559-54-1 | Details |
WAY-607695 | C13H12FNO2 | 380469-52-3 | Details |
TriGalNAc CBz | C34H35NO11 | 186613-57-0 | Details |
Y13g dihydrochloride | Details |
Y13g dihydrochloride, 10 mM in DMSO | Details |
5,6-Benzoflavone, 10 mM in DMSO | C19H12O2 | 6051-87-2 | Details |
XI-006, 10 mM in DMSO | C11H13N5O4 | 58131-57-0 | Details |
(+)-JQ-1, 10 mM in DMSO | C23H25ClN4O2S | 1268524-70-4 | Details |
(-)-(S)-B-973B, 10 mM in DMSO | C24H26F2N6O | 2244989-34-0 | Details |
Vafidemstat, 10 mM in DMSO | C19H20N4O2 | 1357362-02-7 | Details |
TIBI | C7H2I4N2 | 1196457-06-3 | Details |
TP-16 | C24H22FNO4S | 2332972-26-4 | Details |
WAY-297848 | C13H13ClN2O2S | 404360-27-6 | Details |
1-Monopalmitin | C19H38O4 | 542-44-9 | Details |
VK-28, 10 mM in DMSO | C16H21N3O2 | 312611-92-0 | Details |
(Rac)-EC5026, 10 mM in DMSO | C18H23F4N3O3 | 1809885-55-9 | Details |
Tz-Thalidomide, 10 mM in DMSO | C29H29N7O6 | 2087490-42-2 | Details |
Tubulin inhibitor 32 | C18H19N3O3 | 2923531-39-7 | Details |
(-)-Blebbistatin, 10 mM in DMSO | C18H16N2O2 | 856925-71-8 | Details |
α-Demethylnaproxen, 10 mM in DMSO | C13H12O3 | 23981-47-7 | Details |
UCM-13207 | C24H32N2O2 | 1621536-10-4 | Details |
(4E)-SUN9221 | C25H31FN4O3 | 222318-55-0 | Details |
ML 209 | C25H31NO6 | 1334526-14-5 | Details |
WAY-639889 | C25H27N5O | 432506-24-6 | Details |
Wnt/β-catenin agonist 3, 10 mM in DMSO | C16H15ClN4O2 | 912790-59-1 | Details |
USP28-IN-4 | C22H18Cl2N2O3S | 2931509-15-6 | Details |
ZK53 | Details |
Vamotinib, 10 mM in DMSO | C29H27F3N6O | 1416241-23-0 | Details |
TJ08 | C22H16FN3O4 | 2924274-19-9 | Details |
Z-IETD-AFC | C37H42F3N5O13 | 219138-02-0 | Details |
XE991, 10 mM in DMSO | C26H20N2O | 122955-42-4 | Details |
β-Anomer, 10 mM in DMSO | C10H13N3O6 | 356782-84-8 | Details |
UCB7362 hydrochloride | 2610631-18-8 | Details |
ZDLD20 | C22H22N6O | 2762279-02-5 | Details |
(2RS)-FPMPA | C9H13FN5O4P | 135295-27-1 | Details |
YW2036 | C20H16N4O | 2131223-92-0 | Details |
Compound TCFN92660 | C16H16O5 | 56070-89-4 | Details |
Vamifeport, 10 mM in DMSO | C21H21FN6O2 | 2095668-10-1 | Details |
VHL 15a | Details |
Urocortin (rat) acetate | Details |
Transtorine, 10 mM in DMSO | C10H7NO3 | 13593-94-7 | Details |
4''-Methoxyflavanone, 10 mM in DMSO | C16H14O3 | 97005-76-0 | Details |
TGFβ1-IN-1 | C22H24N2O3 | 2348795-14-0 | Details |
Compound TN1582(SC) | C17H18O4 | 60657-93-4 | Details |
WAY-620147 | C12H16BrN3O2 | 515866-67-8 | Details |
β-catenin modulator IIa-661, 10 mM in DMSO | C19H23ClN2O3S | 1015859-04-7 | Details |
XST-14, 10 mM in DMSO | C16H21NO4 | 2607143-50-8 | Details |
Thrombospondin-1 (1016-1023) (human, bovine, mouse), 10 mM in DMSO | C56H81N13O10S | 149234-04-8 | Details |
Triptonoterpene | C20H28O2 | 99694-87-8 | Details |
VV116, 10 mM in DMSO | C24H30DN5O7 | 2647442-33-7 | Details |
VEGFR2-IN-1 | C22H18N6S | 2765224-55-1 | Details |
Thrombin inhibitor 5, 10 mM in DMSO | C11H9FN4O3 | 328108-09-4 | Details |
WAY-616296 | C17H14N2O2S | 503065-67-6 | Details |
(-)-Vorozole | C16H13ClN6 | 132042-69-4 | Details |
(+/-)-Longamide, 10 mM in DMSO | C7H6Br2N2O2 | 219783-00-3 | Details |
Tiaspirone hydrochloride(87691-91-6 Free base), 10 mM in DMSO | C24H33ClN4O2S | 87691-92-7 | Details |
Product Total: Product Page: | ||||
48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 |